We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+23.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$10.7M
Cap. Flow
-$39.5M
Cap. Flow %
-27.17%
Top 10 Hldgs %
27.16%
Holding
316
New
137
Increased
28
Reduced
59
Closed
75

Top Buys

1
CNC icon
Centene
CNC
+$6.93M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$4.78M
3
UNH icon
UnitedHealth
UNH
+$3.65M
4
CVS icon
CVS Health
CVS
+$3.53M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.17M

Top Sells

1
HUM icon
Humana
HUM
+$4.91M
2
EHC icon
Encompass Health
EHC
+$3.58M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$3.43M
4
AMGN icon
Amgen
AMGN
+$3.35M
5
LLY icon
Eli Lilly
LLY
+$2.53M

Sector Composition

1 Healthcare 48.9%
2 Financials 13.82%
3 Technology 6.61%
4 Consumer Discretionary 5.8%
5 Materials 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANAB icon
201
AnaptysBio
ANAB
$1.72B
$23.1K 0.02%
+754
New +$17.3K
RCEL icon
202
CALL
Avita Medical
RCEL
$157M
$22.2K 0.02%
+1,464
New +$7.64K
TVRD
203
Tvardi Therapeutics
TVRD
$30M
$19.5K 0.01%
+500
New +$14.2K
CORT icon
204
PUT
Corcept Therapeutics
CORT
$9.72B
$18.4K 0.01%
61
-128,307
-100% -$9.28M
SLG icon
205
CALL
SL Green Realty
SLG
$3.67B
$16.9K 0.01%
+90
New +$5.33K
FOLD
206
CALL
DELISTED
Amicus Therapeutics
FOLD
$16.7K 0.01%
303
– –
NVDA icon
207
CALL
NVIDIA
NVDA
$4.91T
$16.4K 0.01%
31
-529
-94% -$92.2K
AAPL icon
208
CALL
Apple
AAPL
$4.9T
$16.1K 0.01%
+140
New +$31.6K
SPY icon
209
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$15.2K 0.01%
20
-100
-83% -$64.1K
MU icon
210
CALL
Micron Technology
MU
$959B
$13.7K 0.01%
+12
New +$1.53K
SLNO
211
PUT
DELISTED
Soleno Therapeutics
SLNO
$12.8K 0.01%
+230
New +$17.1K
IBKR icon
212
CALL
Interactive Brokers
IBKR
$40.3B
$12.3K 0.01%
+40
New +$2.52K
ACAD icon
213
CALL
Acadia Pharmaceuticals
ACAD
$4.38B
$11.9K 0.01%
204
– –
SLS icon
214
CALL
SELLAS Life Sciences
SLS
$2.59B
$11.6K 0.01%
920
– –
JBIO
215
PUT
Jade Biosciences
JBIO
$1.27B
$10.2K 0.01%
88
-12,349
-99% -$101K
AFRM icon
216
CALL
Affirm
AFRM
$25.5B
$9.26K 0.01%
23
-43
-65% -$3.27K
PGY icon
217
CALL
Pagaya Technologies
PGY
$1.43B
$8.94K 0.01%
32
-218
-87% -$7.04K
PBYI icon
218
CALL
Puma Biotechnology
PBYI
$434M
$8.66K 0.01%
+312
New +$1.32K
CRVS icon
219
PUT
Corvus Pharmaceuticals
CRVS
$1.25B
$8.27K 0.01%
+114
New +$583
NVAX icon
220
CALL
Novavax
NVAX
$1.35B
$7.78K 0.01%
+399
New +$3.1K
MREO
221
PUT
Mereo BioPharma
MREO
$49.5M
$6.81K ﹤0.01%
91
-2,212
-96% -$4.08K
RC
222
CALL
Ready Capital
RC
$256M
$6.59K ﹤0.01%
+527
New +$2.22K
AGNC icon
223
CALL
AGNC Investment
AGNC
$12.9B
$6.38K ﹤0.01%
+1,618
New +$15.7K
SPY icon
224
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$6.14K ﹤0.01%
+46
New +$29.5K
OEF icon
225
PUT
iShares S&P 100 ETF
OEF
$20.1B
$5.1K ﹤0.01%
60
-68
-53% -$21.6K
7 8
9
10 11

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Persistent Asset Partners held 316 positions worth $145M, up 7.9% from $135M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Persistent Asset Partners withdrew a net $39.5M in Q3 2025, closing 75 positions and reducing 59 holdings. Its most notable exit was Humana, an estimated $4.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 52% a quarter earlier, followed by Financials and Technology.

Against the trend, Persistent Asset Partners opened a new position in Centene worth $8.19M.

  • Persistent Asset Partners's largest Q3 2025 buy was Centene: 229,544 shares worth $8.19M.
  • Persistent Asset Partners added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $3.17M increase.
  • Persistent Asset Partners's biggest Q3 2025 reduction was iShares Bitcoin Trust, cutting an estimated $3.43M.
  • Persistent Asset Partners fully exited Humana in Q3 2025, selling an estimated $4.91M.
  • Persistent Asset Partners's ten largest holdings make up 27% of its $145M portfolio in Q3 2025.
  • Persistent Asset Partners opened 137 new positions and closed 75 in Q3 2025.
  • Persistent Asset Partners's portfolio value rose 7.9% quarter-over-quarter to $145M.

Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.